Serum amyloid A levels in patients with liver diseases

Table 4 Comparison of serum amyloid A levels between active and inactive chronic hepatitis B patients with oral antiviral therapy

Status of patients with antiviral therapy	n	mean ± SD of SAA (mg/L)	Average rank of SAA	Z1 value	P1 value
Active CHB	18	6.289 ± 6.042	74.92	-4.077	0.000
Inactive CHB	82	3.379 ± 4.726	44.46

¹The Mann-Whitney U test was used to compare the serum amyloid A levels between various liver disease groups. SAA: Serum amyloid A; CHB: Chronic hepatitis B.